Value Sense
RVTY
Revvity, Inc. (RVTY)
Last Price$112.9(4.5%)
Market Cap$13.8B
Intrinsic value score
7/10
Good
Intrinsic value
$127.4
DCF value - $124.6 Relative value - $130.2
Undervalued
12.8%
LTM P/E
47.0x
Peer set median 29.2x
Discount rate
7.5%
RVTY
is 12.8% undervalued
learn more -->
50+
undervalued stocks
Start beating the S&P 500

RVTY Intrinsic value

Key Highlights:
Relative Value vs Current Share Price
As of Mar 11, 2025 RVTY Relative Value is $131.8, which is undervalued by 16.7%, compared to current share price of $112.9.
DCF Value vs Current Share Price
As of Mar 11, 2025 RVTY DCF Value is $125.9, which is undervalued by 11.5%, compared to current share price of $112.9.
Methodology
Price per share, $
RVTY
Intrinsic value$127.4
Undervalued by12.8%
Current share price
112.9
Relative value
131.8
DCF value
125.9

Best stock ideas on the market right now

With Value Sense, you can find undervalued stocks list with intrinsic value. Discover more stock market investment ideas.

Undervalued stocks right now

Undervalued stocks right now

Discover the top 20 best undervalued stocks to buy for Mar 2025, listed on the Nasdaq or NYSE.

3M Return 32.1%
S&P Outperformance 19.1%
Next 3M Predicted Return 20.3%
Low P/E stocks

Low P/E stocks

Explore the best low P/E stocks to buy in 2025, featuring top companies trading at low P/E ratios.

3M Return 7.5%
S&P Outperformance -5.5%
Next 3M Predicted Return 10.2%
Undervalued dividend stocks

Undervalued dividend stocks

Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Mar 2025.

3M Return 28.4%
S&P Outperformance 15.4%
Next 3M Predicted Return 16.9%

RVTY Historical Intrinsic Value

Crunching data... Almost there!

RVTY vs Peer Set: Intrinsic Value Comparison

General

Intrinsic Value

Financials

Company name

Undervaluation/Overvaluation

Revenue growth

EPS growth

Net income margin

Revvity, Inc. logo
Revvity, Inc.RVTY
12.8%
0.2%
(58.6%)
9.8%
Median Peer Set
2.1%
4.0%
15.6%
IDEXX Laboratories, Inc. logo
IDEXX Laboratories, Inc.IDXX
(48.3%)
6.5%
6.1%
22.8%
Waters Corporation logo
Waters CorporationWAT
(38.2%)
0.1%
(1.1%)
21.6%
Natera, Inc. logo
Natera, Inc.NTRA
(36.7%)
56.7%
(59.5%)
(11.2%)
Mettler-Toledo International Inc. logo
Mettler-Toledo International Inc.MTD
(32.3%)
2.2%
12.7%
22.3%
Danaher Corporation logo
Danaher CorporationDHR
(20.3%)
(0.1%)
(17.9%)
16.3%
Agilent Technologies, Inc. logo
Agilent Technologies, Inc.A
(19.5%)
(4.7%)
5.2%
19.8%
Thermo Fisher Scientific Inc. logo
Thermo Fisher Scientific Inc.TMO
25.7%
0.1%
6.8%
14.8%
IQVIA Holdings Inc. logo
IQVIA Holdings Inc.IQV
62.5%
2.8%
2.4%
8.9%
ICON Public Limited Company logo
ICON Public Limited CompanyICLR
87.3%
2.0%
28.7%
9.6%
Quest Diagnostics Incorporated logo
Quest Diagnostics IncorporatedDGX
105.5%
6.7%
2.8%
8.8%

Explore more intrinsic value tools hub for RVTY

Peter Lynch Fair Value
Intrinsic Value
Earnings Power Value
Ben Graham Fair Value
Earnings growth model
DCF value calculator
Discount rate
Peter Lynch charts
Reverse DCF
Relative Value

FAQ

What is Revvity, Inc. intrinsic value?

As of Mar 11, 2025, Revvity, Inc. Intrinsic Value is $127.4. This suggests it may be undervalued by 12.8% compared to its current price of around $112.9.

What is Revvity, Inc. DCF (discounted cash flow) valuation?

As of Mar 11, 2025, Revvity, Inc.'s Discounted Cash Flow (DCF) valuation estimates its share price at $125.9. This suggests it may be overvalued by 11.5% to its current price of around $112.9, using a discount rate of 7.5% and terminal growth rate of 3.0%.

Is Revvity, Inc. overvalued or undervalued?

Revvity, Inc. is currently considered undervalued based on its Discounted Cash Flow (DCF) valuation and Relative Valuation, which estimates its share price to be $127.4, compared to a market price of around $112.9. This suggests a potential undervaluation of 12.8%.